Table 2. Outcome measures (Mean±SD).
Experimental group | Control group | |||
---|---|---|---|---|
Pre-test | Post-test | Pre-test | Post-test | |
ASHA NOMS | 2.15±1.40 | 4.46±4.50* | 2.00±0.91 | 4.84±1.40* |
New VFSS (Oral phase) | ||||
Lip closure | 0.30±0.75 | 0.15±0.55 | 0.00±0.00 | 0.00±0.00 |
Bolus formation | 0.46±1.12 | 0.00±0.00 | 1.15±1.51 | 0.69±1.31 |
Mastication | 0.61±1.50 | 0.00±0.00 | 0.00±0.00 | 0.00±0.00 |
Apraxia | 0.11±0.41 | 0.11±0.41 | 0.00±0.00 | 0.00±0.00 |
Tongue to plate contace | 0.76±1.87 | 0.38±1.38 | 1.92±2.53 | 1.38±2.21 |
Premature bolus loss | 1.26±1.60 | 0.46±0.72* | 0.80±0.77 | 0.34±0.65* |
Oral transit time | 0.00±0.00 | 0.23±0.83 | 0.92±1.44 | 0.46±1.12 |
New VFSS (Phayngeal phase) | ||||
Residue in the valleculae | 4.15±1.72 | 1.84±1.28* | 3.07±1.32 | 1.53±1.19* |
Reduced laryngeal elevation and epiglottic closure | 9.00±0.00 | 3.46±4.55* | 8.30±2.49 | 4.15±4.66* |
Residue in the pyriform sinuses | 8.30±2.49 | 4.50±2.59* | 5.88±3.84 | 3.46±3.26* |
Coating of pharyngeal wall after swallow | 9.00±0.00 | 3.46±4.55* | 8.30±2.49 | 6.92±3.94 |
Pharyngeal delay time | 1.38±1.55 | 0.23±0.83* | 1.38±1.55 | 0.00±0.00* |
Pharyngeal transit time | 0.46±1.66 | 0.00±0.00 | 0.46±1.66 | 0.00±0.00 |
Aspiration | 6.92±4.13 | 1.84±4.50* | 7.84±3.78 | 3.23±4.65* |
VFSS TOTAL SCORE | 42.53±8.56 | 17.15±15.43* | 40.07±11.33 | 22.03±12.31* |
*p<0.05. ASHA: American speech-language-hearing association national outcomes measurement system, New VFSS: new videofluoroscopic swallowing study scale